Beam Therapeutics (BEAM) Revenue (2019 - 2026)
Beam Therapeutics (BEAM) reported Revenue of $490,000 for Q2 2026, down 94.2% from $8.47 million a year earlier and down 98.5% from the prior quarter.
Powered by 
Analysis
Beam Therapeutics (BEAM) Revenue (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Beam Therapeutics' Revenue came in at $156.04 million, up 158.9% year-over-year; for FY2025, it came in at $139.74 million, up 120.0% from FY2024.
- Revenue has a five-year compound annual growth rate of 466.3% (FY2020 to FY2025).
- By year, Revenue came in at $63.52 million in FY2024 (-83.2%), $377.71 million in FY2023 (+520.0%), $60.92 million in FY2022 (+17.5%) and $51.84 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Revenue since Q2 2021.
- Year over year, Revenue gained in three of the last eight quarters, with growth averaging 42.9%.
- The high point for year-over-year Revenue in five years was Q1 2026 (growth of 324.9%); the low point was Q2 2026 (a decline of 94.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $31.74 million (Q1 2026), $114.11 million (Q4 2025) and $9.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Beam Therapeutics | 2.50 Bn | 2.50 Bn | - | 490,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 490,000.00 |
| Mar 31, 2026 | 31.74 Mn |
| Dec 31, 2025 | 114.11 Mn |
| Sep 30, 2025 | 9.70 Mn |
| Jun 30, 2025 | 8.47 Mn |
| Mar 31, 2025 | 7.47 Mn |
| Dec 31, 2024 | 30.07 Mn |
| Sep 30, 2024 | 14.27 Mn |
| Jun 30, 2024 | 11.77 Mn |
| Mar 31, 2024 | 7.41 Mn |
| Dec 31, 2023 | 316.19 Mn |
| Sep 30, 2023 | 17.19 Mn |
| Jun 30, 2023 | 20.12 Mn |
| Mar 31, 2023 | 24.21 Mn |
| Dec 31, 2022 | 20.04 Mn |
| Sep 30, 2022 | 15.80 Mn |
| Jun 30, 2022 | 16.65 Mn |
| Mar 31, 2022 | 8.43 Mn |
| Dec 31, 2021 | 51.07 Mn |
| Sep 30, 2021 | 763,000.00 |
API Access
Beam Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=BEAM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "BEAM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=BEAM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();